Human medicines European public assessment report (EPAR): Zeydovio, glepaglutide, Status: Opinion

RegulatoryZeydovioNeutral

AI Analysis

Summary

The European Medicines Agency issued a public assessment report (EPAR) for Zeydovio (glepaglutide) with Opinion status. No specific approval, rejection, or additional details were provided in the announcement.

Outcome Details

European public assessment report (EPAR) issued with Opinion status

Importance:3/10

Sentiment:

0.00

EMAEPARregulatoryglepaglutideZeydovio

Read the original article

Published by EMA New Human Medicines on September 18, 2026 10:05 AM

Read Original